Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.48 |
| ▸ | CXCR4 | P61073 | 8/20 | 0.46 |
| ▸ | CXCL12 | P48061 | 1/20 | 0.46 |
| ▸ | SQLE | Q14534 | 1/20 | 0.45 |
| ▸ | HRH4 | Q9H3N8 | 6/20 | 0.45 |
| ▸ | HRH3 | Q9Y5N1 | 6/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | GNAI3 | P08754 | 2/20 | 0.40 |
| ▸ | GNAO1 | P09471 | 2/20 | 0.40 |
| ▸ | GNAI1 | P63096 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8642198 | 1.00 | SIGMAR1 (0.48) | SIGMAR1CXCR4CXCL12SQLEHRH4 | |
| SCHEMBL16949694 | 1.00 | SIGMAR1 (0.48) | SIGMAR1CXCR4CXCL12SQLEHRH4 | |
| SCHEMBL21011183 | 1.00 | SIGMAR1 (0.48) | SIGMAR1CXCR4CXCL12SQLEHRH4 | |
| SCHEMBL21799618 | 1.00 | SIGMAR1 (0.48) | SIGMAR1CXCR4CXCL12SQLEHRH4 | |
| SCHEMBL21799729 | 1.00 | SIGMAR1 (0.48) | SIGMAR1CXCR4CXCL12SQLEHRH4 | |
| SCHEMBL24383840 | 1.00 | SIGMAR1 (0.48) | SIGMAR1CXCR4CXCL12SQLEHRH4 | |
| SCHEMBL20540217 | 1.00 | SIGMAR1 (0.48) | SIGMAR1CXCR4CXCL12SQLEHRH4 | |
| SCHEMBL21799932 | 1.00 | SIGMAR1 (0.48) | SIGMAR1CXCR4CXCL12SQLEHRH4 | |
| SCHEMBL21799945 | 1.00 | SIGMAR1 (0.48) | SIGMAR1CXCR4CXCL12SQLEHRH4 | |
| SCHEMBL10586487 | 1.00 | SIGMAR1 (0.48) | SIGMAR1CXCR4CXCL12SQLEHRH4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4590036-A | FOR ALKALINE LIQUID SYSTEMS OR ACID GAS ABSORBING SYST*MS | EXXON RESEARCH AND ENGINEERING CO. (US) | 1986-05-20 | — | — | US | claimed |
| US-4344863-A | AMINES, ETHYLENE OXIDE-PROPYLENE OXIDE BLOCK COPOLYMER | EXXON RESEARCH & ENGINEERING CO. (US) | 1982-08-17 | — | — | US | claimed |
| US-4343716-A | IN SCRUBBING ACID GAS | EXXON RESEARCH & ENGINEERING CO. (US) | 1982-08-10 | — | — | US | claimed |
| US-4208385-A | ETHYLENE OXIDE/PROPYLENE OXIDE BLOCK POLYMER ANITFOAM AGENT | EXXON RESEARCH & ENGINEERING CO. (US) | 1980-06-17 | — | — | US | claimed |
| US-4183903-A | Method of removing carbon dioxide from gases utilizing an alkaline absorption solution containing a cyclic urea anti-foaming agent | EXXON RESEARCH & ENGINEERING CO. (US) | 1980-01-15 | — | — | US | claimed |
| EP-3623398-B1 | RESIN COMPOSITION COMPRISING A MODIFIED BLOCK COPOLYMER AND METHOD FOR PRODUCING MODIFIED BLOCK COPOLYMER | ASAHI CHEMICAL IND (JP) | 2024-08-28 | — | — | EP | disclosed |
| CN-110603273-B | Modified block copolymer, method for producing modified block copolymer, and resin composition | 旭化成株式会社 | 2022-10-14 | — | — | CN | disclosed |
| US-11124593-B2 | Modified block copolymer, method for producing modified block copolymer, and resin composition | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2021-09-21 | — | — | US | disclosed |
| US-20200199282-A1 | Modified Block Copolymer, Method for Producing Modified Block Copolymer, and Resin Composition | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2020-06-25 | — | — | US | disclosed |
| EP-3623398-A1 | MODIFIED BLOCK COPOLYMER, METHOD FOR PRODUCING MODIFIED BLOCK COPOLYMER, AND RESIN COMPOSITION | Asahi Kasei Kabushiki Kaisha (JP) | 2020-03-18 | — | — | EP | disclosed |
| CN-110603273-A | Modified block copolymer, method for producing modified block copolymer, and resin composition | 旭化成株式会社 | 2019-12-20 | — | — | CN | disclosed |
| US-9150507-B2 | Amine derivative having NPY Y5 receptor antagonistic activity | SHIONOGI & CO., LTD. (JP) | 2015-10-06 | — | — | US | disclosed |
| US-20100267945-A1 | AMINE DERIVATIVE HAVING NPY Y5 RECEPTOR ANTAGONISTIC ACTIVITY | SHIONOGI & CO., LTD. (JP) | 2010-10-21 | — | — | US | disclosed |
| US-20100063027-A1 | Amine Derivative Having NPY Y5 Receptor Antagonistic Activity | SHIONOGI & CO., LTD. (JP) | 2010-03-11 | — | — | US | disclosed |
| US-20100063027-A1 | Amine Derivative Having NPY Y5 Receptor Antagonistic Activity | SHIONOGI & CO., LTD. (JP) | 2010-03-11 | — | — | US | disclosed |
| EP-0102712-A1 | A process for preventing corrosion in alkaline systems | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1984-03-14 | — | — | EP | disclosed |
| US-4344863-A | AMINES, ETHYLENE OXIDE-PROPYLENE OXIDE BLOCK COPOLYMER | EXXON RESEARCH & ENGINEERING CO. (US) | 1982-08-17 | — | — | US | disclosed |
| US-4343716-A | IN SCRUBBING ACID GAS | EXXON RESEARCH & ENGINEERING CO. (US) | 1982-08-10 | — | — | US | disclosed |
| US-4208385-A | ETHYLENE OXIDE/PROPYLENE OXIDE BLOCK POLYMER ANITFOAM AGENT | EXXON RESEARCH & ENGINEERING CO. (US) | 1980-06-17 | — | — | US | disclosed |
| US-4183903-A | Method of removing carbon dioxide from gases utilizing an alkaline absorption solution containing a cyclic urea anti-foaming agent | EXXON RESEARCH & ENGINEERING CO. (US) | 1980-01-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100063027-A1 | Amine Derivative Having NPY Y5 Receptor Antagonistic Activity | NPY5R, NPY1R, NPY2R | SIGMAR1 57/4885CXCR4 388/4885CXCL12 1802/4885 |
| US-20100267945-A1 | AMINE DERIVATIVE HAVING NPY Y5 RECEPTOR ANTAGONISTIC ACTIVITY | NPY5R, NPY1R, NPY2R | SIGMAR1 77/4885CXCR4 357/4885CXCL12 1614/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.